ImmunityBio converts from Immunomedics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics

IBRX 2.110

-1.4%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

To: CCS648 who wrote (1007)	5/6/2025 2:03:49 PM
From: jargonweary	7 Recommendations of 1229

Having held IMMU for many years and endured similar disappointments I would just observe that the key difference for me is that IMMU eventually (and thankfully) rid itself of its stubborn, selfish, willful and rapacious leadership and installed the kind of smart, shareholder focused management team that was able to drag it across the FDA finish line and deliver tangible value to shareholders and patients. In that case, the whims and failings of the senior leadership of the company could be — and was — successfully overturned by shareholder activism. In the case of IBRX that is not a possibility given the massive ownership level of one individual. I share your views about the potential value of the scientific assets of IBRX and, like you, that is why I am hanging on despite having very serious concerns. However, my tolerance for senior management incompetence is more limited than it was when I was a significantly younger IMMU investor.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next